(UroToday.com) In a GU session at the American Society for Radiation Oncology (ASTRO) Annual Congress, Dr. Glicksman presented pooled results from four prospective trials evaluating the role of elective nodal ultra hypofractionated radiation in treatment of patients with prostate cancer.